AstraZeneca's Coronavirus Vaccine Is Already Being Reviewed for Approval in Canada and Europe. Why Not in the U.S.?

AstraZeneca's Coronavirus Vaccine Is Already Being Reviewed for Approval in Canada and Europe. Why Not in the U.S.?

Source: 
Motley Fool
snippet: 

AstraZeneca has fallen behind over the last four weeks -- at least in the U.S. Early last month, the company announced that it was temporarily pausing its late-stage clinical studies evaluating COVID-19 vaccine candidate AZD1222. AstraZeneca has since resumed its trials in multiple countries; indeed, AZD1222 is already being reviewed for potential regulatory approvals in Canada and Europe.